Over 10 years experience of Traceability Solutions
By pharmatrax
Category: Technoloy
No CommentsFirms ramping up innovation efforts in new sectors like high-quality drugs and biologics As China moves forward from being the world’s manufacturing powerhouse to an…
By pharmatrax
Category: Technoloy
No CommentsAlphabet Inc. (NASDAQ:GOOG) managers are incubating vibrant new businesses in pharma and tech This might seem a particularly bad time to be investing in big…
By pharmatrax
Category: News
No CommentsChina and India are both major API suppliers and generic-heavy countries. Because of the similarity, Indian drugmakers have long had a hard time finding an…
By pharmatrax
Category: News
No CommentsThe Khyber Pakhtunkhwa Provincial Quality Control Board (PQCB) has ordered to lodged 11 FIRs against sellers of fake and sub-standard medicines while several cases has…
By pharmatrax
Category: Technoloy
No CommentsAs healthcare takes strides towards digitisation, the e-pharma industry hopes for Government support to streamline electronic records, make healthcare affordable and give a boost to…
By pharmatrax
Category: News
No CommentsSubstandard and counterfeit drugs can negatively impact the pharmaceutical industry and patients. Here, we investigate counterfeits in south-east Asia and possible solutions. Counterfeit and falsified…
By pharmatrax
Category: News
No CommentsValisure warns FDA officials that the pharmacy found high levels of dimethylformamide in valsartan, a heart pill manufactured by Novartis. Valisure is an online pharmacy…
By pharmatrax
Category: News
No CommentsFrom automated eye scans to analysing the cries of new-born babies, faster drug development to personalised medicine, artificial intelligence (AI) promises huge advances in the…
By pharmatrax
Category: Technoloy
No CommentsSanofi will apply Google’s artificial intelligence (AI) and cloud computing capabilities toward developing new drugs, through a collaboration whose value was not disclosed. The companies…
By pharmatrax
Category: Technoloy
No CommentsPoliticians and even knowledgeable industry observers have called for price controls to deal with what many see as a crisis in drug pricing. Can pricing boards do…